Study of Rituximab Plus High-Dose Chemotherapy Non-Hodgkin's Lymphoma

Clinical trial NCT00143871 · COMPLETED

Trial details

NCT number: NCT00143871
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, Non-Hodgkin's

Start date: 2001-04-01
Primary completion: 2006-12-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.